Ignite Creation Date:
2024-05-06 @ 9:57 AM
Last Modification Date:
2024-10-26 @ 12:21 PM
Study NCT ID:
NCT03111732
Status:
COMPLETED
Last Update Posted:
2021-12-03
First Post:
2017-04-12
Brief Title:
Pembrolizumab a Monoclonal Antibody Against PD-1 in Combination With Capecitabine and Oxaliplatin CAPOX in People With Advanced Biliary Tract Carcinoma BTC
Sponsor:
National Cancer Institute NCI
Organization:
National Institutes of Health Clinical Center CC